P/E ratio for Bio-Techne (TECH)
P/E ratio as of July 2025 (TTM): 70.5
According to Bio-Techne's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 70.5422. At the end of 2024 the company had a P/E ratio of 72.0.
P/E ratio history for Bio-Techne from 2001 to 2025
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2024 | 72.0 | 32.56% |
| 2023 | 54.3 | 9.49% |
| 2022 | 49.6 | -48.39% |
| 2021 | 96.2 | 38.09% |
| 2020 | 69.6 | 62.43% |
| 2019 | 42.9 | -24.75% |
| 2018 | 57.0 | 34.58% |
| 2017 | 42.3 | -13.13% |
| 2016 | 48.7 | 44.58% |
| 2015 | 33.7 | 14.55% |
| 2014 | 29.4 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Thermo Fisher Scientific TMO | 28.4 | -59.77% | 🇺🇸 USA |
 Bio-Rad Laboratories BIO | -3.32 | -104.71% | 🇺🇸 USA |
 Becton Dickinson BDX | 34.8 | -50.60% | 🇺🇸 USA |
 Danaher DHR | 39.1 | -44.57% | 🇺🇸 USA |
 Qiagen QGEN | 119 | 69.03% | 🇳🇱 Netherlands |
 General Electric GE | 41.8 | -40.80% | 🇺🇸 USA |
 Enzo Biochem ENZB | -3.24 | -104.59% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.